Autosomal dominant hypocalcemia in monozygotic twins caused by a De Novo germline mutation near the amino-terminus of the human calcium receptor

被引:22
|
作者
Hu, JX
Mora, S
Weber, G
Zamproni, I
Proverbio, MC
Spiegel, AM
机构
[1] Natl Inst Deafness & Other Commun Disorders, Mol Pathophysiol Sect, NIH, Bethesda, MD 20892 USA
[2] Vita Salute San Raffaele Univ, Lab Pediat Endocrinol, Milan, Italy
[3] Vita Salute San Raffaele Univ, Dept Pediat, Milan, Italy
[4] Univ Milan, Dipartimento Sci & Tecnol Biomed, Milan, Italy
关键词
autosomal dominant hypocalcemia; human calcium receptor; activating mutation; Venus flytrap-like domain; loop; 2;
D O I
10.1359/JBMR.040106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To define the molecular pathogenesis of severe postnatal hypocalcemia in monozygotic twin sisters, we sequenced their CaR gene and identified a missense mutation, K29E. Expression of the mutant receptor in vitro showed a marked increase in Ca2+ sensitivity explaining the observed phenotype. Additional mutagenesis studies lead us to speculate concerning a novel mechanism whereby the K29E mutation may lead to receptor activation. Introduction: Activating mutations of the Ca2+-sensing receptor (CaR) gene have been identified in subjects with autosomal dominant hypocalcemia. Study of such mutations has provided insight into the mechanism of activation of the CaR. Materials and Methods: We performed biochemical and molecular genetic studies on monozygotic twin sisters who presented with early postnatal hypocalcemia and on their unaffected sister and parents. Functional characterization of mutant CaRs transfected in HEK-293 cells included immunoblots to monitor protein expression and Ca2+ stimulation of phosphoinositide hydrolysis to measure Ca2+ sensitivity. Results: We identified a K29E missense mutation in the twin sisters but not in their parents or unaffected sister. The K29E mutant CaR showed a marked increase in Ca2+ sensitivity, including when it was co-transfected with wildtype CaR cDNA, consistent with a dominant effect. Substitution of K 29 by aspartate equivalently increased CaR sensitivity, whereas conservative substitution by arginine did not. Conclusions: Severe postnatal hypocalcemia in the twin sisters was caused by a de novo germline activating mutation. In a model of the Venus flytrap-like domain of the extracellular amino-terminus of the CaR, K 29 is located close to a peptide loop, "loop 2," that forms part of the dimer interface and is the site of 10 of the previously reported naturally occurring activating CaR mutations. We speculate that K29E increases Ca2+ sensitivity of the CaR by disrupting a salt bridge between K 29 and an acidic residue in loop 2 and thereby changes the normal structure of loop 2 that maintains the CaR in its inactive conformation.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 32 条
  • [21] A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia
    Hirai, H
    Nakajima, S
    Miyauchi, A
    Nishimura, K
    Shimizu, N
    Shima, M
    Michigami, T
    Ozono, K
    Okada, S
    JOURNAL OF HUMAN GENETICS, 2001, 46 (01) : 41 - 44
  • [22] A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia
    H. Hirai
    S. Nakajima
    A. Miyauchi
    K. Nishimura
    N. Shimizu
    M. Shima
    T. Michigami
    K. Ozono
    S. Okada
    Journal of Human Genetics, 2001, 46 : 41 - 44
  • [23] A Novel Activating Mutation of Calcium Sensing Receptor Gene in a Girl with Autosomal Dominant Hypocalcemia and Type 5 Bartter Syndrome: Successful Treatment with Recombinant Human Parathyroid Hormone
    Numbenjapon, Nawaporn
    Lumpaopong, Adisorn
    Thirakhupt, Prapaipim
    Thanakitcharu, Kwanja
    Boonyawat, Boonchai
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [24] Autosomal dominant hypocalcemia: A novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor
    Tan, YM
    Cardinal, J
    Franks, AH
    Mun, HC
    Lewis, N
    Harris, LB
    Prins, JB
    Conigrave, AD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02): : 605 - 610
  • [25] A case of severe autosomal dominant spinal muscular atrophy with lower extremity predominance caused by a de novo BICD2 mutation
    Ueda, Yuki
    Suganuma, Takashi
    Narumi-Kishimoto, Yoko
    Kaname, Tadashi
    Sato, Tomonobu
    BRAIN & DEVELOPMENT, 2021, 43 (01): : 135 - 139
  • [26] Genetic mosaicism for de novo mutations of the calcium sensing receptor (CASR) gene:: Implications for recurrence risks in autosomal dominant hypoparathyroidism
    Cole, D. E. C.
    Wong, B. Y. L.
    Canaff, L.
    Hendy, G. N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S498 - S498
  • [27] The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
    Hannan, Fadil M.
    Walls, Gerard V.
    Babinsky, Valerie N.
    Nesbit, M. Andrew
    Kallay, Enikoe
    Hough, Tertius A.
    Fraser, William D.
    Cox, Roger D.
    Hu, Jianxin
    Spiegel, Allen M.
    Thakker, Rajesh V.
    ENDOCRINOLOGY, 2015, 156 (09) : 3114 - 3121
  • [28] A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium:: Identification of a novel gain of function mutation (Ser820Phe) in the calcium-sensing receptor
    Nagase, T
    Murakami, T
    Tsukada, T
    Kitamura, R
    Chikatsu, N
    Takeo, H
    Takata, N
    Yasuda, H
    Fukumoto, S
    Tanaka, Y
    Nagata, N
    Yamaguchi, K
    Akatsu, T
    Yamamoto, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2681 - 2687
  • [29] Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics
    Zung, Amnon
    Barash, Galia
    Banne, Ehud
    Levine, Michael A.
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (05): : 473 - 482
  • [30] A patient with pontine autosomal dominant microangiopathy and leukoencephalopathy caused by a de novo 3′ untranslated region mutation of COL4A1 gene: case report and literature review
    Xie, Fei
    Li, Shuang
    Hu, Xingyue
    Li, Wenyu
    NEUROLOGICAL SCIENCES, 2025,